DEFA14A: IBEX Forms Nominating Committee to Enhance Governance

IBEX Limited has established a formal Nominating Committee to address shareholder concerns and enhance its corporate governance structure.

Summary

• IBEX Limited's Board of Directors established a formal Nominating Committee on November 20, 2025.
• Previously, independent board members exclusively performed these functions, which was compliant with Nasdaq Global Market rules.
• The Committee's primary responsibilities include identifying, evaluating, and recommending qualified director candidates, and developing criteria for candidates.
• Independent Directors Daniella Ballou-Aares (Chair), Karen Batungbacal, Fiona Beck, Patrick McGinnis, and Mingzhe (JJ) Zhuang were appointed as members of the Committee.
• The formation addresses "perceived deficiencies" in the nominating process expressed by Institutional Shareholder Services Inc. and Glass Lewis & Co., LLC.
• The Committee ratified prior actions and renominated the slate of director candidates for the upcoming annual meeting on December 5, 2025.
• The newly formed Committee and the full Board unanimously recommend a vote FOR each of the nominees.

Sentiment

Score: 7

Explanation: The filing indicates a proactive and positive step towards improving corporate governance by formalizing the nominating process and addressing shareholder concerns, which is generally viewed favorably. The prompt for this action (perceived deficiencies) prevents a higher score, but the resolution is positive.

Positives

• Formalizes the director nomination process, potentially improving transparency and accountability in corporate governance.
• Directly addresses specific concerns raised by influential proxy advisory firms, Institutional Shareholder Services Inc. and Glass Lewis & Co., LLC.
• All appointed committee members are independent, aligning with best governance practices and Nasdaq listing standards.
• The company believes these actions fully rectify the previously perceived deficiencies in the nominating process.

Negatives

• The establishment of the committee was prompted by "perceived deficiencies" in the prior nominating process, indicating past governance weaknesses.

Risks

• Potential for continued scrutiny from proxy advisory firms if the new committee's actions or future nominations are not deemed sufficiently effective or transparent.

Future Outlook

The company anticipates that the establishment of the formal Nominating Committee will fully rectify the perceived deficiencies in its nominating process and enhance its corporate governance, leading to improved shareholder confidence.

Management Comments

• "The Company believes that these actions fully rectify those concerns [expressed by Institutional Shareholder Services Inc. and Glass Lewis & Co., LLC]."
• "The newly formed Committee, and the full Board, unanimously recommend a vote FOR each of the nominees."

Industry Context

The move reflects a broader trend in corporate governance where companies are increasingly responsive to feedback from institutional shareholders and proxy advisory firms to ensure robust and transparent board nomination processes. This is particularly relevant for companies listed on major exchanges like Nasdaq, which have specific independence requirements for director nominations.

Comparison to Industry Standards

• The establishment of a formal Nominating Committee aligns with best practices in corporate governance, as many large public companies maintain such committees to ensure a structured and independent approach to director selection.
• Addressing concerns from Institutional Shareholder Services Inc. and Glass Lewis & Co., LLC is a common practice for companies seeking to maintain strong governance ratings and shareholder support, similar to how companies like Apple or Microsoft regularly review and update their governance structures based on stakeholder feedback.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive impact due to enhanced corporate governance and responsiveness to proxy advisory firm feedback, potentially leading to increased confidence in board selection and overall company oversight.
• Board of Directors: Clarified roles and responsibilities for director nominations, with a dedicated committee to manage the process.

Next Steps

• Shareholders are urged to vote FOR each of the Board nominees at the upcoming annual meeting on December 5, 2025.
• Shareholders who previously submitted a proxy for the annual meeting may send in a new proxy to change their vote, which will automatically supersede the prior proxy.

Key Dates

Recommendation

The filing details a positive step in corporate governance by formalizing the Nominating Committee and addressing prior concerns from proxy advisory firms. While this is a favorable development for long-term stability and investor confidence, it does not present new financial performance data or strategic shifts that would warrant a 'buy' or 'sell' recommendation. It primarily reinforces good governance practices, suggesting a 'hold' for existing investors who value sound corporate structure.

Keywords

IBEX Limited, Nominating Committee, Corporate Governance, Board of Directors, SEC Filing, Proxy Statement, Nasdaq, Institutional Shareholder Services, Glass Lewis